Results 331 to 340 of about 224,992 (367)
Anti-CD20 alone as maintenance immunosuppressive therapy in severe lupus nephritis: a promising experience that needs to be evaluated. [PDF]
Lupus Sci MedBoutinet S +5 more
europepmc +1 more source
Identification of protein biomarker candidates associated with organ-specific immune-related toxicity and response to management by plasma proteomics. [PDF]
BMJ OncolKverneland AH +6 more
europepmc +1 more source
Erratum: MicroRNA-203 Expression as Potential Biomarker for Lupus Nephritis [Corrigendum]. [PDF]
Int J Nephrol Renovasc Diseuropepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Nature Reviews Disease Primers, 2020
Lupus nephritis (LN) is a form of glomerulonephritis that constitutes one of the most severe organ manifestations of the autoimmune disease systemic lupus erythematosus (SLE). Most patients with SLE who develop LN do so within 5 years of an SLE diagnosis and, in many cases, LN is the presenting manifestation resulting in the diagnosis of SLE ...
H. Anders +5 more
semanticscholar +3 more sources
Lupus nephritis (LN) is a form of glomerulonephritis that constitutes one of the most severe organ manifestations of the autoimmune disease systemic lupus erythematosus (SLE). Most patients with SLE who develop LN do so within 5 years of an SLE diagnosis and, in many cases, LN is the presenting manifestation resulting in the diagnosis of SLE ...
H. Anders +5 more
semanticscholar +3 more sources
Arthritis & Rheumatism, 2012
OBJECTIVE To evaluate the efficacy and safety of rituximab in a randomized, double-blind, placebo-controlled phase III trial in patients with lupus nephritis treated concomitantly with mycophenolate mofetil (MMF) and corticosteroids.
B. Rovin +10 more
semanticscholar +1 more source
OBJECTIVE To evaluate the efficacy and safety of rituximab in a randomized, double-blind, placebo-controlled phase III trial in patients with lupus nephritis treated concomitantly with mycophenolate mofetil (MMF) and corticosteroids.
B. Rovin +10 more
semanticscholar +1 more source
Journal of Veterinary Emergency and Critical Care, 2013
ObjectiveTo review what is known and highlight knowledge gaps regardingLyme nephritis (LN).Data SourcesPublications identified via PubMed using the keywords “Borrelia burgdorferi,” “Borreliosis,” “glomerulonephritis,” “protein‐losing nephropathy,” “autoimmunity,” and “retriever,” and as generated by investigators working in the fields ofBorreliosis and
openaire +3 more sources
ObjectiveTo review what is known and highlight knowledge gaps regardingLyme nephritis (LN).Data SourcesPublications identified via PubMed using the keywords “Borrelia burgdorferi,” “Borreliosis,” “glomerulonephritis,” “protein‐losing nephropathy,” “autoimmunity,” and “retriever,” and as generated by investigators working in the fields ofBorreliosis and
openaire +3 more sources